Related Experiment Video
Updated: Jan 13, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Liquid Biopsy and Automated Next-Generation Sequencing: Achieving Results in 27 Hours Within a Community Setting
Tomomi Yajima1,2, Fumitake Hata1, Sei Kurokawa3
1Department of Surgery, Sapporo Dohto Hospital, 14-3-2 Kita 17-jo Higashi, Higashi-ku, Sapporo 065-0017, Japan.
Rapid, automated cell-free DNA (cfDNA) genomic profiling using next-generation sequencing (NGS) is now feasible in community hospitals. This breakthrough delivers comprehensive results in under 27 hours, accelerating precision oncology decisions.
Area of Science:
- Oncology
- Genomics
- Molecular Diagnostics
Background:
- Conventional next-generation sequencing (NGS) workflows are lengthy, delaying critical treatment decisions in precision oncology.
- Current NGS limitations restrict access to advanced genomic profiling in community healthcare settings.
More Related Videos
05:17Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016